ProQR Therapeutics Statistics
Total Valuation
PRQR has a market cap or net worth of $153.52 million. The enterprise value is $62.89 million.
Market Cap | 153.52M |
Enterprise Value | 62.89M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
Earnings Date | Aug 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PRQR has 81.66 million shares outstanding.
Shares Outstanding | 81.66M |
Owned by Insiders (%) | 18.87% |
Owned by Institutions (%) | 39.04% |
Float | 57.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.47 |
Forward PS | 5.48 |
PB Ratio | 4.06 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.29 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.55.
Current Ratio | 3.11 |
Quick Ratio | 3.10 |
Debt / Equity | 0.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -62.19 |
Financial Efficiency
Return on equity (ROE) is -61.60% and return on invested capital (ROIC) is -56.52%.
Return on Equity (ROE) | -61.60% |
Return on Assets (ROA) | -19.50% |
Return on Capital (ROIC) | -56.52% |
Revenue Per Employee | $93,620 |
Profits Per Employee | -$186,324 |
Employee Count | 157 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | -81,426 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.50% in the last 52 weeks. The beta is 0.42, so PRQR's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | +17.50% |
50-Day Moving Average | 1.81 |
200-Day Moving Average | 1.88 |
Relative Strength Index (RSI) | 58.67 |
Average Volume (20 Days) | 82,101 |
Short Selling Information
Short Interest | 171,723 |
Short Previous Month | 173,172 |
Short % of Shares Out | 0.30% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.68 |
Income Statement
In the last 12 months, PRQR had revenue of $14.66 million and -$29.18 million in losses. Loss per share was -$0.36.
Revenue | 14.66M |
Gross Profit | 14.64M |
Operating Income | -33.16M |
Pretax Income | -29.23M |
Net Income | -29.18M |
EBITDA | -25.88M |
EBIT | -28.76M |
Loss Per Share | -$0.36 |
Balance Sheet
The company has $111.51 million in cash and $20.87 million in debt, giving a net cash position of $90.64 million or $1.11 per share.
Cash & Cash Equivalents | 111.51M |
Total Debt | 20.87M |
Net Cash | 90.64M |
Net Cash Per Share | $1.11 |
Equity (Book Value) | 37.80M |
Book Value Per Share | 0.46 |
Working Capital | 78.97M |
Cash Flow
In the last 12 months, operating cash flow was -$42.20 million and capital expenditures $6.50 million, giving a free cash flow of -$35.70 million.
Operating Cash Flow | -42.20M |
Capital Expenditures | 6.50M |
Free Cash Flow | -35.70M |
FCF Per Share | -$0.44 |
Margins
Gross margin is 99.88%, with operating and profit margins of -226.19% and -199.02%.
Gross Margin | 99.88% |
Operating Margin | -226.19% |
Pretax Margin | -199.34% |
Profit Margin | -199.02% |
EBITDA Margin | -176.53% |
EBIT Margin | -196.19% |
FCF Margin | -243.51% |
Dividends & Yields
PRQR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.84% |
Shareholder Yield | -0.84% |
Earnings Yield | -19.01% |
FCF Yield | -23.25% |
Analyst Forecast
The average price target for PRQR is $3.38, which is 79.79% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.38 |
Price Target Difference | 79.79% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 38.25% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |